Sustainability | March 20, 2025
UFlex’s FlexiTubes to showcase sustainable beauty packaging at COSMOPROF Italy 2025
FlexiTubes will showcase range of eco-friendly and innovative tube options
FlexiTubes will showcase range of eco-friendly and innovative tube options
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Expertise in exosomes isolation and characterization will drive innovation in this field
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
AMPLIFY Phase III trial results demonstrated statistically significant and clinically meaningful improvement in progression-free survival for Calquence combinations
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
EBITDA grew 46.9% YoY to Rs. 210.3 crore with EBITDA margin at 18.2%, grew 401 bps YoY and the reported PAT at Rs. 90 crore
Subscribe To Our Newsletter & Stay Updated
